11/04/2024
5:02 AM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/08/2024
4:46 PM | Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
| Form 144/A | |
10/08/2024
4:48 PM | Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
| Form 144/A | |
10/03/2024
7:48 PM | Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:50 PM | Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
5:03 AM | Belite Bio (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/20/2024
11:40 AM | Belite Bio (Subject)
Liaw Wei-Cheng (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/04/2024
11:29 AM | Belite Bio (Subject)
Chen Wan-Shan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
7:00 AM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024
5:24 PM | Belite Bio (Subject)
MATA NATHAN L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
1:38 PM | Belite Bio (Subject)
Chiu Ching Chen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:30 PM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
2:17 PM | Belite Bio (Subject)
MATA NATHAN L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
3:45 PM | Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
3:47 PM | Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
10:36 AM | Belite Bio (Subject)
MATA NATHAN L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
1:23 PM | Belite Bio (Subject)
Chiu Ching Chen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
8:57 PM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
12:37 PM | Belite Bio (Filer)
| Form 424B5 | |
04/25/2024
8:02 PM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024
10:26 AM | Belite Bio (Subject)
Chen Wan-Shan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
7:00 AM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
2:58 PM | Belite Bio (Subject)
MATA NATHAN L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
7:51 PM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
8:05 PM | Belite Bio (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/11/2024
8:59 PM | Belite Bio (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
8:08 PM | Belite Bio (Subject)
Lin Yu-Hsin (Filed by)
| Form SC 13G | |
02/12/2024
7:40 PM | Belite Bio (Subject)
Lin Bioscience International Ltd. (Filed by)
| Form SC 13G | |
12/28/2023
3:15 PM | Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
3:16 PM | Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
